Search Results

You are looking at 41 - 50 of 173 items for :

  • Refine by Access: All x
Clear All
Full access

NCCN Virtual Policy Summit: Defining the “New Normal” — 2021 and the State of Cancer Care in America Following 2020

Alyssa A. Schatz, Lindsey Bandini, and Robert W. Carlson

US healthcare systems have been deeply impacted by significant societal shifts over the past several years. The COVID-19 pandemic has changed the way we interact with healthcare, political narratives have impacted how healthcare is perceived and

Full access

CLO22-043: Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Large, Single-Center Observational Study

Peter G Doukas, Frederique St Pierre, Jennifer Boyer, Mariana Nieves, and Shuo Ma

Full access

The Future of Telemedicine in Oncology

Presented by: Lucy R. Langer, Amye J. Tevaarwerk, and Robin Zon

Moderated by: Travis Osterman

The Clinician Perspective Telemedicine refers to a remote clinical service between a patient and healthcare professional. Although it may seem that telemedicine was not widely used until the onset of the COVID-19 pandemic, the concept is

Full access

Changes in Prescribing Patterns in Stage III Colon Cancer

Fang-Shu Ou, Daniel J. Walden, Joseph J. Larson, Sandra Kang, Cassia R. Griswold, Benjamin E. Ueberroth, Bhamini Patel, Amber Draper, Puneet Raman, Olatunji B. Alese, Mohamad B. Sonbol, Tanios S. Bekaii-Saab, Christina S. Wu, and Daniel H. Ahn

abstract presentation at the 2017 ASCO Annual Meeting (June 2–6, 2017) and the full manuscript publication (March 29, 2018). The gray zones indicate the interval from the first US patient diagnosed with COVID-19 to the first stay-at-home order (California

Full access

Implementation of INHERET, an Online Family History and Cancer Risk Interpretation Program for Primary Care and Specialty Clinics

Lynn A. McCain, Kara J. Milliron, Amanda M. Cook, Robert Paquette, Jasmine B. Parvaz, Susan D. Ernst, Anne L. Kittendorf, Diane M. Harper, Philip Zazove, Jim Arthurs, Jerry A. Tippie, Bailey Hulswit, Lee F. Schroeder, David F. Keren, and Sofia D. Merajver

-point scale). (C) Understandability (scores of ≥3 on a 5-point scale). Note: 2019 Q4 and 2020 Q1 are omitted due to restructuring of clinics during the COVID-19 pandemic. Abbreviations: GC, genetics clinic; PCC, primary care clinic; Q, quarter

Full access

Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology

Narek Shaverdian, Erin F. Gillespie, Elaine Cha, Soo Young Kim, Stephanie Benvengo, Fumiko Chino, Jung Julie Kang, Yuelin Li, Thomas M. Atkinson, Nancy Lee, Charles M. Washington, Oren Cahlon, and Daniel R. Gomez

Background The coronavirus disease 2019 (COVID-19) pandemic has transformed cancer care in the United States with the rapid expansion of telemedicine into routine patient evaluation and management. 1 Patients with cancer are vulnerable to

Full access

Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma

Ashwin Rao, Nicole E. Rich, Jorge A. Marrero, Adam C. Yopp, and Amit G. Singal

, determinants, and impact of delays in HCC care is timely in light of the ongoing COVID-19 pandemic and its impact on healthcare delivery. In a recent American Cancer Society survey, 50% of patients with cancer reported disrupted access to healthcare, including

Full access

Loneliness and Mortality Risk Among Cancer Survivors in the United States: A Retrospective, Longitudinal Study

Jingxuan Zhao, Jennifer B. Reese, Xuesong Han, and K. Robin Yabroff

importance as a medical issue was underscored by the widespread social isolation imposed by the COVID-19 pandemic. 15 A study of healthy individuals in Sweden found that those who self-reported having a high level of loneliness had a 27% higher mortality

Full access

HSR22-178: Real World Outcomes of Cancer Patients With SARS-CoV-2 Infection Receiving Monoclonal Antibodies

Alexa Wilden, Aishwarya Sannareddy, Hetal Patel, Shraddha Kansagra, Gurbakhash Kaur, Praveen Ramakrishnan, Prapti Patel, Ansh Mehta, and Ankit Kansagra

two monoclonal antibodies (MAbs), casirivimab/imdevimab and bamlanivimab, for treating mild/moderate COVID-19. In this real-world retrospective study, we aim to evaluate the efficacy of monoclonal antibody therapy in patients with and without a history

Full access

EPR22-114: Acceptance of SARS-CO-2 Vaccination Among Cancer Patients: Experience of Radiation Therapy Center in Tunisia

Rihab Melliti, R. Melliti, S. Tbessi, A. Chamsi, H. Ouaz, F. Bouguerra, S. Belajouza, N. Bouzid, and S. Tebra

INTRODUCTION : Coronavirus vaccination is strongly recommended for cancer patients. However, there is a limited data regarding cancer patients’ attitudes towards COVID -19 vaccination. We aim to evaluate cancer patients’ willingness to take